Position in EXEL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$15,842,124
+$9,118,474 QoQ
Shares Held
291,162
+85.7% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#104
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Derivatives in EXEL
reported options exposure · as of Mar 31, 2020CallValue
$3,444
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,801,971 across 115 Biotechnology names. EXEL ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in EXEL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,842,124 | 291,162 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,723,650 | 156,765 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,125,930 | 48,504 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,602,516 | 87,228 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,146,518 | 71,382 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,990,446 | 80,998 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,501,462 | 75,119 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,679,691 | 64,728 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,499,490 | 66,733 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,818,975 | 76,653 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,306,782 | 96,156 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,384,809 | 63,378 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,214,975 | 63,578 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $813,259 | 41,899 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $645,032 | 40,214 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $508,455 | 32,427 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $630,762 | 30,296 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $664,367 | 29,306 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $597,152 | 32,667 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $729,456 | 34,506 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $631,887 | 34,681 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $825,438 | 36,540 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $753,849 | 37,561 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $840,762 | 34,387 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $910,785 | 38,365 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $654,997 | 38,037 | Shares | Sole | 2020-05-21 | |
| 2020-03-31 | $3,444 | 200 | Call | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||